SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Nvwm LLC

Nvwm LLC lessened its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 6.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 11,829 shares of the exchange traded fund’s stock after selling 858 shares during the quarter. Nvwm LLC’s holdings in SPDR S&P Biotech ETF were worth $1,065,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of XBI. Money Concepts Capital Corp raised its position in SPDR S&P Biotech ETF by 6.0% in the fourth quarter. Money Concepts Capital Corp now owns 245,148 shares of the exchange traded fund’s stock valued at $22,078,000 after purchasing an additional 13,875 shares during the period. Lion Street Advisors LLC raised its stake in shares of SPDR S&P Biotech ETF by 11.4% in the fourth quarter. Lion Street Advisors LLC now owns 4,393 shares of the exchange traded fund’s stock valued at $396,000 after acquiring an additional 450 shares in the last quarter. Tempus Wealth Planning LLC boosted its stake in shares of SPDR S&P Biotech ETF by 8.3% in the 4th quarter. Tempus Wealth Planning LLC now owns 3,080 shares of the exchange traded fund’s stock valued at $277,000 after buying an additional 236 shares during the period. Means Investment CO. Inc. lifted its stake in SPDR S&P Biotech ETF by 1.3% in the fourth quarter. Means Investment CO. Inc. now owns 106,773 shares of the exchange traded fund’s stock worth $9,616,000 after acquiring an additional 1,407 shares during the last quarter. Finally, MilWealth Group LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter worth $65,000.

SPDR S&P Biotech ETF Stock Performance

XBI opened at $92.57 on Wednesday. SPDR S&P Biotech ETF has a one year low of $81.14 and a one year high of $105.47. The business’s 50-day simple moving average is $92.99 and its 200-day simple moving average is $96.59. The company has a market cap of $7.06 billion, a P/E ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.